This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is NOT a problem in face to face interviewing? a. Safety b. Expense c. ... (Read 118 times)

asan beg

  • Hero Member
  • *****
  • Posts: 570
Which of the following is NOT a problem in face to face interviewing?
 
  a. Safety
  b. Expense
  c. Difficult to supervise interviewers
  d. Problems in answering questions in the intended order

Question 2

Before you ask survey respondents how often they smoke, you should first ask
 
  a. Their name
  b. Whether they drink
  c. How often they drink
  d. Whether they smoke at all



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

akudia

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

d

Answer to Question 2

d




asan beg

  • Member
  • Posts: 570
Reply 2 on: Jun 20, 2018
Gracias!


JaynaD87

  • Member
  • Posts: 368
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

In most cases, kidneys can recover from almost complete loss of function, such as in acute kidney (renal) failure.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

A cataract is a clouding of the eyes' natural lens. As we age, some clouding of the lens may occur. The first sign of a cataract is usually blurry vision. Although glasses and other visual aids may at first help a person with cataracts, surgery may become inevitable. Cataract surgery is very successful in restoring vision, and it is the most frequently performed surgery in the United States.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library